hair loss on a glp-1

Not directly, in the way a chemotherapy drug does. Alopecia was reported as an uncommon adverse event in the semaglutide obesity trials, in a small percentage of participants and at low absolute rates, and it appears more often in the studies with the largest and fastest weight loss. That pattern points at the weight loss as the trigger rather than the molecule.

The mechanism is well described outside of GLP-1s entirely. Rapid weight loss and low energy availability are recognised triggers of telogen effluvium, and it has been documented after bariatric surgery and crash dieting for decades. A GLP-1 produces the same conditions, quickly and reliably, which is why the same effect follows.

Because of how the hair cycle works. Each follicle spends years in a growth phase, then a short transitional phase, then roughly three months resting before the hair is released and a new one pushes it out. A stress event shifts many follicles into the resting phase at the same time, and nothing visible happens while they rest.

The shedding you notice in the shower is therefore a delayed echo, typically two to three months behind the trigger. This also explains the most confusing part for people: the hair often starts falling out at the point where they are feeling best about their progress, and it usually continues for a few months before settling.

Telogen effluvium is self-limiting. Shedding typically runs for about three to six months and then stops on its own, with regrowth following as those follicles restart. Because new hairs grow roughly a centimetre a month, visible thickness takes longer to return than the shedding takes to stop, which tests your patience more than your follicles.

The shedding becomes chronic mainly when the trigger stays in place. Continuing very low intake, continuing very rapid loss, or an unaddressed deficiency will keep pushing new follicles into rest. Slowing the rate of loss and correcting intake is the intervention, not a shampoo.

Protein first. Hair is largely keratin, a protein, and follicles are among the most metabolically active tissues in the body, so they are early casualties of a shortfall. The intake that protects muscle during weight loss, around 1.6 grams per kilogram of bodyweight a day, is a sensible floor here too, and it is harder to hit on a GLP-1 precisely because appetite is suppressed.

Then the micronutrients with an actual evidence base in hair loss: iron, zinc, vitamin D, and B12. Deficiency in these is associated with hair shedding and is more likely when total intake drops. Testing before supplementing is the sensible order, since excess of some nutrients, selenium and vitamin A in particular, can itself cause hair loss.

It is the most direct lever you have. Telogen effluvium tracks the severity of the stressor, so a gentler rate of loss and adequate intake alongside it reduce the odds of triggering it at all. If you have already started shedding, easing the deficit and getting protein up will not regrow hair overnight, but it stops adding new follicles to the resting pile.

This is also a case where the medication decision is not yours alone to make. If shedding is distressing, that is a legitimate thing to raise with your prescriber, who can discuss the pace of dose escalation. What is entirely inside your control is what you eat while the medication does its work.

See a clinician if the shedding is patchy rather than evenly diffuse, if the scalp is itchy, scaly, or painful, if you are losing hair from your eyebrows or body as well, or if it continues beyond about six months. Those patterns suggest something other than simple telogen effluvium.

Also worth checking regardless: thyroid function, ferritin, vitamin D, and B12. Thyroid disease and iron deficiency both cause diffuse hair loss, both become more likely to be noticed during a period of dieting, and both are straightforward to treat once identified. A blood test converts an anxious guess into an answer.